|
Ironwood is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines targeting important therapeutic needs. Our goal is to build the next great pharmaceutical company—an outstanding business that will thrive and endure well beyond our lifetimes and generate substantial returns for our shareholders.
05.14.2012
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012
05.08.2012
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference
05.01.2012
Ironwood Pharmaceuticals Provides First Quarter 2012 Investor Update
04.24.2012
Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call
04.23.2012
Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
View all releases »
|
